Dr. Mrozek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
803 W Market St
Ste 200
Lima, OH 45805Phone+1 419-222-3737Fax+1 419-229-3234- Is this information wrong?
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2002 - 2005
- New York-Presbyterian Brooklyn Methodist HospitalResidency, Internal Medicine, 1996 - 1999
- Gdański Uniwersytet MedycznyClass of 1983
Certifications & Licensure
- OH State Medical License 1999 - 2024
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer Start of enrollment: 2005 Sep 01
- Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer Start of enrollment: 2008 Jul 01
- Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer Start of enrollment: 2010 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsPhase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine P...Robert Wesolowski, Daniel G. Stover, Maryam B. Lustberg, Abigail B. Shoben, Meng Zhao, Ewa Mrozek, Rachel M. Layman, Erin Macrae, Wenrui Duan, Jun Zhang, Nathan Hall, ...> ;The Oncologist. 2020 Aug 1
- 20 citationsA phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer.Sagar Sardesai, Mohamed Badawi, Ewa Mrozek, Evan Morgan, Mitch A. Phelps, Julie A. Stephens, Lai Wei, Mahmoud Kassem, Yonghua Ling, Maryam B. Lustberg, Daniel G. Stove...> ;Investigational New Drugs. 2020 Jan 17
- 50 citationsCirculating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancerRobert Wesolowski, Megan C. Duggan, Andrew Stiff, Joseph Markowitz, Prashant Trikha, Kala M. Levine, Lynn Schoenfield, Mahmoud Abdel-Rasoul, Rachel M. Layman, Bhuvanes...> ;Cancer Immunology, Immunotherapy. 2017 Jul 7
- Join now to see all
Press Mentions
- Fitness More Important Than Age in Choosing Treatment for DiseaseDecember 27th, 2015
Hospital Affiliations
- The OSUCCC - JamesColumbus, Ohio
- Mercy Health - St. Rita's Medical CenterLima, Ohio
- Madison HealthLondon, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: